Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Rajgor Castor Derivatives Ltd

RCDL
NSE
23.00
4.17%
Last Updated:
30 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Rajgor Castor Derivatives Ltd

RCDL
NSE
23.00
4.17%
30 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
55Cr
Close
Close Price
23.00
Industry
Industry
Solvent Extraction
PE
Price To Earnings
6.17
PS
Price To Sales
0.09
Revenue
Revenue
626Cr
Rev Gr TTM
Revenue Growth TTM
-3.93%
PAT Gr TTM
PAT Growth TTM
9.58%
Peer Comparison
How does RCDL stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
RCDL
VS

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025
Revenue
RevenueCr
225204191374278347279
Growth YoY
Revenue Growth YoY%
-15.383.745.8-7.10.4
Expenses
ExpensesCr
226192182362272332273
Operating Profit
Operating ProfitCr
-1128125166
OPM
OPM%
-0.36.04.33.22.04.52.2
Other Income
Other IncomeCr
0000020
Interest Expense
Interest ExpenseCr
1133353
Depreciation
DepreciationCr
1111111
PBT
PBTCr
-111693133
Tax
TaxCr
0022131
PAT
PATCr
-2836272
Growth YoY
PAT Growth YoY%
241.8-18.8-48.813.6-5.2
NPM
NPM%
-1.13.91.81.70.62.10.6
EPS
EPS
0.00.00.03.40.73.00.7

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
113141040429565625626
Growth
Revenue Growth%
-87.6-30.3307.0980.831.710.70.2
Expenses
ExpensesCr
110131037417545604605
Operating Profit
Operating ProfitCr
210312202122
OPM
OPM%
2.09.7-1.36.82.73.63.43.5
Other Income
Other IncomeCr
01110022
Interest Expense
Interest ExpenseCr
12222588
Depreciation
DepreciationCr
11111112
PBT
PBTCr
1-1-309141416
Tax
TaxCr
00-103454
PAT
PATCr
0-1-2161099
Growth
PAT Growth%
-369.9-85.7129.0962.476.5-7.9-1.0
NPM
NPM%
0.3-6.9-18.51.31.31.71.41.4
EPS
EPS
418.5-82.3-152.96.330.15.23.83.7

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity Capital
Equity CapitalCr
000022424
Reserves
ReservesCr
4312225059
Current Liabilities
Current LiabilitiesCr
41415294811070
Non Current Liabilities
Non Current LiabilitiesCr
191096642
Total Liabilities
Total LiabilitiesCr
2726263878188155
Current Assets
Current AssetsCr
3321657164133
Non Current Assets
Non Current AssetsCr
24232322212323
Total Assets
Total AssetsCr
2726263878188155

Cash Flow

Standalone
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
2237-40-3411
Investing Cash Flow
Investing Cash FlowCr
-23-1-30-1-41
Financing Cash Flow
Financing Cash FlowCr
21-10-74138-12
Net Cash Flow
Net Cash FlowCr
0000000
Free Cash Flow
Free Cash FlowCr
-20237-41-3710
CFO To PAT
CFO To PAT%
588.9-230.5-148.11,406.4-724.8-352.1122.5
CFO To EBITDA
CFO To EBITDA%
92.1165.1-2,128.2272.7-348.9-170.652.4

Ratios

Standalone
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
000008341
Price To Earnings
Price To Earnings
0.00.00.00.00.08.54.5
Price To Sales
Price To Sales
0.00.00.00.00.00.10.1
Price To Book
Price To Book
0.00.00.00.00.01.10.5
EV To EBITDA
EV To EBITDA
7.913.8-161.26.53.86.44.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
5.510.60.97.25.55.54.7
OPM
OPM%
2.09.7-1.36.82.73.63.4
NPM
NPM%
0.3-6.9-18.51.31.31.71.4
ROCE
ROCE%
7.34.5-1.012.715.015.517.0
ROE
ROE%
8.3-29.4-120.325.923.413.210.8
ROA
ROA%
1.3-3.7-7.01.47.15.25.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Rajgor Castor Derivatives Limited (**RCDL**) is an Indian manufacturer and trader specializing in castor oil and its derivatives. Since a strategic management change in **January 2022**, the company has transitioned from a pure trading and leasing model to an integrated manufacturing entity. Following its successful listing on the **NSE Emerge** platform in **October 2023**, RCDL has positioned itself as a high-growth player in the global agro-chemical and industrial feedstock markets. ### Integrated Manufacturing and Strategic Sourcing Ecosystem RCDL operates a state-of-the-art manufacturing facility in **Harij, Gujarat**, with a robust production capacity of **450 MT per day**. The facility’s location is a core competitive advantage, providing proximity to both supply and distribution hubs. * **Sourcing Advantage:** Gujarat accounts for approximately **80%** of India’s castor seed production. RCDL procures raw materials directly from local farmers and **APMCs** (Agricultural Produce Market Committees), ensuring supply chain security. * **Logistical Efficiency:** The plant is strategically located near the **Mundra Port**, facilitating cost-effective international distribution and supporting the company's aggressive export expansion. * **Operational Maintenance:** The company maintains high industrial standards, though it undergoes scheduled annual maintenance (e.g., a month-long shutdown in **August-September**) which can cause temporary production fluctuations. ### Specialized Product Portfolio and Industrial Utility The company focuses on high-purity oil and nutrient-dense derivatives catering to pharmaceutical, cosmetic, and agricultural sectors. | Product Category | Key Specifications | Primary Applications | | :--- | :--- | :--- | | **Refined Castor Oil (F.S.G.)** | **First Special Grade**; meets **British Standard Specifications**. | **Pharmaceuticals** (tablet coatings), **Cosmetics**, **Lubricants**, and **Biodiesel**. | | **Castor De-Oiled Cake (D.O.C.)** | Rich in **Nitrogen, Phosphorus, and Potassium (NPK)**. | **Organic Fertilizer** for soil health and moisture retention. | | **High Protein Castor Meal (HPCM)** | **>50% Protein content**; balanced amino acid profile. | **Livestock Feed Supplement** for poultry, cattle, and aquaculture. | The refining process for **F.S.G. Oil** is specifically designed to remove allergenic proteins and toxins like **ricin**, making it a critical precursor for medicinal and high-end industrial applications. ### Financial Performance and Capital Structure RCDL has demonstrated significant revenue scaling, crossing the **₹625 Crore** mark in **FY25**. The **October 2023 IPO** (Fresh issue of **8,895,000 shares** at **₹50** per share) significantly strengthened the balance sheet. **Key Financial Metrics:** | Metric (₹ Crore) | FY23 (Audited) | FY24 (Audited) | FY25 (Audited) | | :--- | :--- | :--- | :--- | | **Total Revenue** | 428.78 | 564.84 | **625.40** | | **Net Profit (PAT)** | 5.54 | 9.78 | **9.01** | | **Net Worth** | 23.66 | 74.22 | **83.00** | | **Total Debt** | 44.51 | 47.44 | **53.63** | **Solvency and Liquidity:** * **Gearing Ratio:** Improved drastically from **1.87x** (FY23) to **0.51x** (FY25). * **Current Ratio:** Stands at a healthy **1.92 times** (FY25). * **Credit Rating:** Reaffirmed at **IVR BBB/ Stable** (Long Term) and **IVR A3+** (Short Term) by Infomerics in February 2026. * **Operating Cycle:** Elongated to **35 days** in FY24 (from **13 days** in FY23) as a strategic move to boost sales volumes. ### Strategic Growth Pillars and Global Expansion The company is transitioning from a domestic manufacturer to a global supplier, leveraging the "China Plus One" sentiment in global supply chains. * **Export Surge:** Export turnover grew by over **430%** in a single year, rising from **₹3.97 Crore** in FY24 to **₹21.06 Crore** in FY25, targeting markets in the **USA, Singapore, and Thailand**. * **Capital Headroom:** Shareholders approved an increase in authorized capital from **₹24 Crore** to **₹56.50 Crore** (effective April 2026) and raised the **FII/FPI limit to 100%** to invite global institutional investment. * **Leadership Stability:** **Mr. Brijeshkumar Vasantlal Rajgor** has been re-appointed as Managing Director through **August 2030**, ensuring long-term strategic continuity. * **Digitalization:** Implementation of **smart manufacturing** systems to improve traceability and quality control for pharmaceutical-grade clients. ### Related Party Ecosystem and Synergies RCDL operates within a broader group of "sister concern" companies that optimize the supply chain and mitigate demand risks through arm's-length transactions. * **Key Entities:** Rajgor Agro Limited, Rajgor Proteins Limited, Exaoil Refinery Limited, and Koovey Oleo Science Private Limited. * **Transaction Thresholds:** For **FY 2025-26**, the company sought approval for material related party transactions (RPTs) up to **₹100 Crore** each for Rajgor Proteins and Rajgor Agro, reflecting the deep integration of the group's manufacturing and trading activities. ### Risk Profile and Mitigation Strategies Despite a stable outlook, RCDL faces several inherent industry risks: * **Commodity and Raw Material Risk:** India’s castor seed production is forecasted to drop to **15.6 lakh tonnes** in FY25 (from **20.54 lakh tonnes**). RCDL mitigates this through its proximity to Gujarat's primary growing regions and active **hedging** of product prices. * **Geographical Concentration:** Approximately **94%** of FY25 revenue is derived from **Gujarat and Maharashtra**. Expansion into international markets is the primary strategy to de-risk this concentration. * **Macroeconomic and Geopolitical Factors:** Tensions in the **Red Sea** and the **Russia-Ukraine** conflict have historically impacted freight costs and lead times. The company manages this through cautious inventory planning and forex hedging. * **Substitution Risk:** Castor-based derivatives compete with **crude-based** alternatives. RCDL counters this by emphasizing the **ESG and sustainability** benefits of bio-based products to global buyers. * **Regulatory Compliance:** The company monitors stringent international quality standards for its pharmaceutical exports and has addressed minor technical non-compliances (such as a brief delay in appointing a Company Secretary) to align with **SEBI LODR** regulations.